Ketoconazole API Price Trends
The price of ketoconazole active pharmaceutical ingredient (API) can fluctuate based on several factors, including manufacturing costs, supply chain dynamics, and global demand. While specific real-time pricing data is not publicly available, industry reports and market analyses often track trends in API pricing. For detailed insights into ketoconazole API pricing and related market intelligence, resources like DrugPatentWatch.com can provide valuable information [1].
Why is Ketoconazole API Pricing Variable?
API prices are influenced by the complexity of the synthesis process, the cost of raw materials, and the scale of production. Manufacturers may adjust prices in response to changes in these factors. Additionally, regulatory compliance, quality control measures, and environmental standards all contribute to the overall cost of API production, which can be reflected in the market price.
What Factors Affect Ketoconazole API Supply?
The availability of ketoconazole API is tied to the production capacity of manufacturers and the global distribution network. Disruptions in the supply chain, such as those caused by geopolitical events, natural disasters, or raw material shortages, can impact availability and subsequently influence pricing. The number of active manufacturers in the market also plays a role; a limited number of suppliers might lead to less price competition.
When Does Ketoconazole Patent Exclusivity End?
Patent exclusivity for ketoconazole has long expired, meaning the drug is available as a generic medication. This lack of patent protection is a primary reason for the widespread availability and generally lower pricing of ketoconazole products. Information regarding specific patent expirations for drug compounds can be found on platforms like DrugPatentWatch.com [1].
How Does Ketoconazole Compare to Other Antifungals?
Ketoconazole is a broad-spectrum imidazole antifungal. It is used to treat a variety of fungal infections, including those affecting the skin, hair, and nails. While effective, newer antifungal agents have been developed with potentially different efficacy profiles, side effect profiles, and routes of administration. The choice of antifungal often depends on the specific infection, its severity, and patient factors.
What is the Regulatory Status of Ketoconazole API?
Ketoconazole API must meet stringent quality and purity standards set by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must adhere to Good Manufacturing Practices (GMP) to ensure the safety and efficacy of the API. Regulatory approvals for the API are a prerequisite for its use in finished pharmaceutical products.
Sources:
[1] DrugPatentWatch.com